We strongly believe that targeting TNFR2 using its proper antagonist is an effective way to treat cancer as it efficiently controls immunosuppression, tumor angiogenesis, tumor neurogenesis, and survival. The gene discussed is TNFRSF1B; the disease is neoplasm.